Founder at My Own Med
Vicki Seyfert-Margolis founded My Own Med in January 2013, based on more than two years of work on a health management-based family technology database, web and mobile application platform.
Previously, she Vicki was Senior Advisor for Scientific and Policy Innovation in the Office of the Commissioner of the United States Food and Drug Administration (FDA)
Prior to the FDA, she served as Chief Scientific Officer at the Immune Tolerance Network (ITN), a non-profit consortium of researchers seeking new treatments for diseases of the immune system. At ITN, Vicki oversaw the development of more than 20 centralized laboratory facility developments.
She designed and implemented biomarker discovery studies during more than 25 Phase II clinical trials across a wide range of immunologically mediated diseases including autoimmune disorders, allergy, and solid organ transplantation.
Previously, she served as Director of the Office of Scientific Research Innovative Technologies at the National Institute of Allergy and Infectious, in the United States.
Categorías de conocimiento
Today’s cities are not sustainable, at least not as they are being designed and used. In fact, over the last decades, urban sprawl and informal settlements have increased, up to a point where 56% of the world’s (urban) population accounts for 66% of energy consumption and 70% of emissions.
Herramientas como las habilidades blandas, la capacidad de comunicación, el uso de la tecnología o el pensamiento crítico son parte del camino hacia un futuro líquido en educación.
Could digital medicine increase our life expectancy? Hopes (without hype) for a promising future.
